Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1329 of 5804
-
New pill combo aims to tame advanced prostate cancer
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy, and safety of HRS-5041 tablets combined with antitumor therapy in subjects with advanced prostate cancer.
Phase: PHASE1, PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Can a pill and patch help dual users kick the smoking habit?
Disease control Recruiting nowThe overarching goal of this research is to determine the most effective approach for helping dual users of cigarettes and electronic nicotine delivery systems (ENDS) quit smoking. 500 participants will be enrolled and can expect to be on study for 12 months.
Phase: PHASE4 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Migraine prevention drug atogepant under Real-World review in korea
Prevention Recruiting nowMigraine is a neurological disease characterized by moderate or severe headache, associated with nausea, vomiting, and/or sensitivity to light and sound. The study will assess the safety and effectiveness of atogepant for the preventive treatment of migraine in Korean adult patie…
Sponsor: AbbVie • Aim: Prevention
Last updated Jul 24, 2026 00:00 UTC
-
Gene therapy RJK002 injected into spine for ALS – first human test begins
Disease control OngoingThe goal of the study aims to evaluate the safety and tolerability of a single intrathecal injection of RJK002 in subjects with amyotrophic lateral sclerosis (ALS), and to determine the recommended Phase II dose (RP2D).
Phase: PHASE1 • Sponsor: RJK Biopharma Ltd • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New inhaler aims to quiet chronic cough
Symptom relief OngoingThis is a phase 2b, randomized, double-blind, placebo-controlled study investigating the efficacy, safety, and tolerability of Taplucainium Inhalation Powder (NOC-110) once daily in adults with refractory or unexplained chronic cough.
Phase: PHASE2 • Sponsor: Nocion Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Can a dengue vaccine shield you from zika? new study investigates
Prevention CompletedZika virus (ZIKV) is an illness people can get from mosquitoes. The infection is generally mild with symptoms that include a fever, rash, red eyes, and joint pain, though most of those infected have no symptoms. Preventing ZIKV is important because if a pregnant person is infecte…
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Prevention
Last updated Jun 27, 2026 11:00 UTC
-
Chilling the ear canal during cochlear implant surgery may protect residual hearing
Symptom relief Recruiting nowThe goal of this interventional clinical study is to investigate the use of mild therapeutic hypothermia for preservation of residual hearing in cochlear implant surgery. The main questions the trial aims to answer are: 1. Is mild therapeutic hypothermia safe for use during coch…
Phase: NA • Sponsor: Restorear Devices LLC • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
New Immune-Boosting drug combo targets Hard-to-Treat cancers
Disease control Recruiting nowThis study is researching an experimental drug called REGN10597 alone or in combination with another drug called cemiplimab (called "study drug(s)"). The study is focused on patients with certain solid tumors that are in an advanced stage. The aim of the study is to see how safe…
Phase: PHASE1, PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New therapy helps veterans with PTSD by targeting 'Safety Behaviors'
Symptom relief CompletedThe purpose of this project is to examine the acceptability, feasibility, and utility of a safety aid reduction treatment (START) among Veterans with posttraumatic stress disorder (PTSD). It is hypothesized that START will be acceptable, feasible, and will lead to reductions in P…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
Blood test could spare thousands of preemies from unnecessary antibiotics
Diagnosis Recruiting nowIn the Netherlands, more than 85% of the preterm infants born \<32 weeks gestational age get antibiotics directly after birth because of the risk of infection with a bacteria. However, only 1 in 70 of these preterm babies actually has a bacterial infection. The use of antibiotics…
Phase: NA • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Diagnosis
Last updated Jun 27, 2026 07:52 UTC
-
New Follow-Up program aims to ease emotional pain after crisis
Symptom relief CompletedCrisis stabilization centers (CSCs) provide a less costly and more comfortable alternative to Emergency Department care for individuals with suicidal crises. With demand for crisis alternatives growing, effective interventions that fit the unique workflows and workforce of CSCs a…
Phase: NA • Sponsor: University of Rochester • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
Magic mushroom compound tested for cancer pain that opioids Can't touch
Symptom relief Recruiting nowThe overall objective of this study is to assess the feasibility, safety and preliminary efficacy of psilocybin-assisted therapy to alleviate opioid-refractory pain in patients with advanced-cancer. The name of the study intervention used in this research study is: Psilocybin (…
Phase: PHASE2 • Sponsor: Yvan Beaussant, MD, MSci • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
New combo aims to stall bile duct cancer after chemo
Disease control Recruiting nowThe aim of this study is to investigate whether the combination of durvalumab and olaparib in the maintenance setting after initial chemotherapy and durvalumab will benefit patients with locally advanced or metastatic cholangiocarcinoma.
Phase: PHASE2 • Sponsor: Australasian Gastro-Intestinal Trials Group • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Knee pain breakthrough? PRP and stem cells face off in new trial
Disease control ENROLLING_BY_INVITATIONThe goal of this randomized clinical trial is to compare treatment for osteoarthritis in the knee using platelet rich plasma (PRP) or adipose stem cells (ADS). The main questions it aims to answer are: * Will the patients clinically benefit from the treatment, and if so, which t…
Phase: PHASE2, PHASE3 • Sponsor: University Hospital of North Norway • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Robot vs. surgeon: which is better for uterine cancer surgery?
Disease control Recruiting nowThe standard treatment for endometrial cancer is surgery, as long as the stage of the disease and the patient's condition allow. It consists of hysterectomy (TSH) with bilateral adnexectomy. The recommended surgical approach is the minimally invasive or laparoscopic route, whose …
Phase: NA • Sponsor: Rennes University Hospital • Aim: Disease control
Last updated Jun 26, 2026 17:13 UTC
-
New combo therapy aims to ease tough schizophrenia symptoms
Symptom relief Recruiting nowsigma-1 receptor (S1R) agonistic property have been tested in clinical trials for the treatment of schizophrenia. In addition, previous studies found that some NMDA receptor (NMDAR)-enhancing agents were able to improve clinical symptoms of patients with chronic schizophrenia. Wh…
Phase: PHASE2 • Sponsor: China Medical University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Cancer pill shows promise against tough brain tumor
Disease control Recruiting nowThe focus of this study will be to investigate whether Regorafenib demonstrates antitumor activity against recurrent meningiomas. Small trials and case series suggest clinical relevant activity of several VEGF inhibitors such as sunitinib, bevacizumab and valatinib reporting a 6…
Phase: PHASE2 • Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New light therapy could fade Port-Wine stains
Disease control Recruiting nowThis is a multi-center, randomized, double-blind, vehicle-controlled, and sequential group Phase 2 study. Eligible subjects aged 18 to 75 years old with PWB will receive Hemoporfin PDT or vehicle PDT in 8-week cycles at fixed drug dose (5 mg/kg) and different light fluence.
Phase: PHASE2 • Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Could new imaging probes spot breast cancer more accurately?
Diagnosis Recruiting nowThe aim of this study is to establish and optimize the Trop2/HER2-targeted PET/CT imaging method, and its physiological and pathological distribution characteristics, on the basis of which the diagnostic efficacy of the above imaging agents in breast cancer will be evaluated.
Phase: PHASE1, PHASE2 • Sponsor: RenJi Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 09:00 UTC
-
New hope for stomach cancer: experimental drug combo trial opens
Disease control Recruiting nowThis is a phase 1/2, multicenter, open-label umbrella platform study that will evaluate the safety and tolerability of investigational agents with pembrolizumab and fluoropyrimidine chemotherapy for the first-line (1L) treatment of participants with locally advanced unresectable …
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC